Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis

Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis

This study was designed to explore the effects of ivabradine on cardiomyocyte apoptosis in a murine model of chronic viral myocarditis (CVMC). Mice were inoculated intraperitoneally with Coxsackievirus B3 at days 1, 14, and 28, respectively. On day 42, the mice were gavaged with ivabradine for 30 da...

Full description

Bibliographic Details
Main Authors:	Ge Li-Sha, Liu Li, Zhou De-Pu, Shi Zhe-Wei, Gu Xiaohong, Chen Guang-Yi, Li Jia, Lin Jia-Feng, Chu Maoping, Li Yue-Chun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-03-01
Series:	Frontiers in Pharmacology
Subjects:	coxsackievirus chronic viral myocarditis heart rate ivabradine cardiomyocyte apoptosis
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2018.00182/full

Similar Items

Corrigendum: Ivabradine Treatment Reduces Cardiomyocyte Apoptosis in a Murine Model of Chronic Viral Myocarditis
by: Ge Li-Sha, et al.
Published: (2019-09-01)

The protective effects of ivabradine in preventing progression from viral myocarditis to dilated cardiomyopathy
by: Li Yue-Chun, et al.
Published: (2016-11-01)

Mechanisms and Therapeutic Strategies of Viral Myocarditis Targeting Autophagy
by: Kun Yu, et al.
Published: (2022-04-01)

STAT3 Suppresses Cardiomyocytes Apoptosis in CVB3-Induced Myocarditis Via Survivin
by: Qiaoyu Wang, et al.
Published: (2021-01-01)

Melatonin Ameliorates Coxsackievirus B3-Induced Myocarditis by Regulating Apoptosis and Autophagy
by: Yimiao Sang, et al.
Published: (2018-12-01)

PhIP-Seq Reveals Autoantibodies for Ubiquitously Expressed Antigens in Viral Myocarditis
by: Mahima T. Rasquinha, et al.
Published: (2022-07-01)

In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell<sup>®</sup> Cardiomyocytes
by: Lisa Kraft, et al.
Published: (2021-09-01)

MicroRNA‐425‐3p inhibits myocardial inflammation and cardiomyocyte apoptosis in mice with viral myocarditis through targeting TGF‐β1
by: Junhua Li, et al.
Published: (2021-03-01)

CD11b is involved in coxsackievirus B3-induced viral myocarditis in mice by inducing Th17 cells
by: Wei Heng, et al.
Published: (2020-12-01)

Sex-Specific Effects of Plastic Caging in Murine Viral Myocarditis
by: Katelyn A. Bruno, et al.
Published: (2021-08-01)

IL-9 inhibits viral replication in Coxsackievirus B3-induced myocarditis
by: Miao Yu, et al.
Published: (2016-10-01)

Treatment Trends of Myocarditis with Coxsackievirus B3 infection
by: Dalya Basil Hanna, et al.
Published: (2020-06-01)

The Evolution of Pleconaril: Modified <i>O</i>-Alkyl Linker Analogs Have Biological Activity towards Coxsackievirus B3 Nancy
by: Alexandrina Volobueva, et al.
Published: (2020-03-01)

Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes
by: Soo-Hyeon Yun, et al.
Published: (2020-04-01)

An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine
by: Yue Gao, et al.
Published: (2021-09-01)

Macrophage-Specific Coxsackievirus and Adenovirus Receptor Deletion Enhances Macrophage M1 Polarity in CVB3-Induced Myocarditis
by: Ha-Hyeon Shin, et al.
Published: (2023-03-01)

ROLE OF HEART RATE REDUCTION WITH IVABRADINE IN LEFT VENTRICULAR FAILURE IVABRADINE AND HEART RATE REDUCTION IN LEFT VENTRICULAR FAILURE
by: Safia Batool, et al.
Published: (2020-12-01)

Gr-1+ Cells Other Than Ly6G+ Neutrophils Limit Virus Replication and Promote Myocardial Inflammation and Fibrosis Following Coxsackievirus B3 Infection of Mice
by: Dan Xu, et al.
Published: (2018-05-01)

Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01)

The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4+ T cell differentiation
by: Zhou De-Pu, et al.
Published: (2018-12-01)

The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels
by: Benjamin Hackl, et al.
Published: (2022-05-01)

Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis
by: Kathleen Pappritz, et al.
Published: (2022-04-01)

Vaccines against Group B Coxsackieviruses and Their Importance
by: Kiruthiga Mone, et al.
Published: (2023-01-01)

Coxsackievirus B3 directly induced Th17 cell differentiation by inhibiting Nup98 expression in patients with acute viral myocarditis
by: Qi Long, et al.
Published: (2016-12-01)

Miocarditis fulminante y enfermedad diarreica aguda por Coxsackie virus B6 Fulminant myocarditis and acute gastroenteritis due to Coxsackie virus B6
by: Germán Málaga, et al.
Published: (2011-03-01)

NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy
by: Qing Kong, et al.
Published: (2022-01-01)

Myocarditis in Humans and in Experimental Animal Models
by: Przemysław Błyszczuk, et al.
Published: (2019-05-01)

IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01)

The Biological Effects of Ivabradine in Cardiovascular Disease
by: Graziano Riccioni, et al.
Published: (2012-04-01)

Mid cristal atrial tachycardia and ivabradine: A Case Report
by: Debasish Das, et al.
Published: (2021-01-01)

Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis
by: Xiaoli Yang, et al.
Published: (2019-03-01)

The possibilities of usage of ivabradin (Coraxan) in elderly and senile patients with the syndrome of polymorbidity
by: A. N Ilnitskij, et al.
Published: (2013-12-01)

Designing a multi-epitope vaccine against coxsackievirus B based on immunoinformatics approaches
by: Sichao Huang, et al.
Published: (2022-11-01)

Viral Myocarditis: Clinical and Paraclinical Diagnosis
by: Gabriela CEOBANU, et al.
Published: (2020-06-01)

Vagus nerve plays a pivotal role in CD4+ T cell differentiation during CVB3-induced murine acute myocarditis
by: Li Yue-Chun, et al.
Published: (2021-12-01)

IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER
by: E. I. Tarlovskaya
Published: (2018-04-01)

Observational study of new-onset atrial fibrillation in patients treated with Ivabradine alone versus Ivabradine and β-blocker drug (The BetaBrad Study)
by: Rohan S Thanedar, et al.
Published: (2022-01-01)

Opioid-Induced Immunomodulation: Consequences for the Experimental Coxsackievirus B3-Induced Myocarditis Model
by: Kathleen Pappritz, et al.
Published: (2020-10-01)

Ivabradine in Chronic Heart Failure
by: Hadeer Eid, et al.
Published: (2020-06-01)

Roles of inflammasomes in viral myocarditis
by: Jingyu Xu, et al.
Published: (2023-05-01)